Simpson Thacher represented Goldman Sachs & Co. LLC as the underwriter in connection with the offering by certain affiliates of Warburg Pincus LLC and GTCR, LLC of an aggregate of 20,000,000 shares of common stock of Sotera Health Company (“Sotera Health”). The offering raised approximately $302 million in aggregate gross proceeds for the selling stockholders and closed on September 5, 2025.
Sotera Health is a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry. Sotera Health is committed to its mission, Safeguarding Global Health®.
The Simpson Thacher team for this transaction included John O’Connell, Kirsten Harmon, Nate Yang and Jeryne Fish (Capital Markets); Vanessa Burrows and Jacob Madden (Healthcare); Mike Isby (Environmental); Pasco Struhs (Executive Compensation and Employee Benefits); Jonathan Cantor, Sean Largey and Heesang Yeo (Tax); Andrew Pagliughi (FINRA & Blue Sky); and Corina Holland and Alex Kokka (IP).